To assess whether the high CD44 expression observed in BMAT-rich sites was exclusive to T-ALL or may also occur in B-ALL, we analyzed CD44 expression in three B-ALL samples from different oncogenic groups (Supplementary Table 1). The gene discussed is CD44; the disease is precursor B-cell acute lymphoblastic leukemia.